Day One

10:15 am - 11:00 am

Discussing the Current Anti-CGRP Status & the Challenges & Opportunities They Pose

Synopsis Understand pathophysiology data from imaging studies Summarize new guidelines on developing Acute Treatment for Migraine Assess treatment gaps in Preventive treatment of Migraine and the unmet patient needRead more


  • Daniel Mikol

    Daniel Mikol
    Executive Medical Director - Global Neuroscience Development Amgen